 |
|
||||||||
|
|||||||||
PreviousLabco
In July 2008, Electra invested €30 million in the €150 million equity capital increase by
Labco SAS.
Paris-based Labco is Europe’s largest private network of clinical laboratories. With a presence in six countries, Labco has over 300 laboratories conducting over 250,000 blood and urine tests per day and serving ten million patients each year.
Market growth is derived from an ageing European population, advances in medical technology and an increasing propensity for preventative testing. With a dominant market position in France and Spain, Labco is a leading consolidator of the European laboratory sector which is currently highly fragmented.
The capital increase was used to finance the acquisition of a number of laboratories in Belgium, France, Germany, Italy and Spain. Financial performance in the eight months to August 2009 was in line with budget with revenues of over €300 million.
Labco SAS.
Paris-based Labco is Europe’s largest private network of clinical laboratories. With a presence in six countries, Labco has over 300 laboratories conducting over 250,000 blood and urine tests per day and serving ten million patients each year.
Market growth is derived from an ageing European population, advances in medical technology and an increasing propensity for preventative testing. With a dominant market position in France and Spain, Labco is a leading consolidator of the European laboratory sector which is currently highly fragmented.
The capital increase was used to finance the acquisition of a number of laboratories in Belgium, France, Germany, Italy and Spain. Financial performance in the eight months to August 2009 was in line with budget with revenues of over €300 million.